Adiponectin levels and expression of adiponectin receptors in isolated monocytes from overweight patients with coronary artery disease
By Anastasios Kollias, Panayoula C Tsiotra, Ignatios Ikonomidis, Eirini Maratou, Panayota Mitrou, Erifyli Kyriazi, Eleni Boutati, John Lekakis, Theofanis Economopoulos, Dimitrios T Kremastinos, George Dimitriadis and Sotirios A Raptis
(2001). Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation
(2006). Adiponectin and mortality in patients undergoing coronary angiography.
(2009). Adiponectin isoforms are not associated with the severity of coronary atherosclerosis but with undiagnosed diabetes in patients affected by stable CAD. Nutr Metab Cardiovasc Dis
(2010). Adiponectin primes human monocytes into alternative anti-inflammatory M2 macrophages. Am J Physiol Heart Circ Physiol
(2006). Adiponectin receptors in human adipose tissue: effects of obesity, weight loss, and fat depots. Obesity (Silver Spring)
(2004). Adiponectin specifically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophages. Circulation
(2005). Adiponectin, risk of coronary heart disease and correlations with cardiovascular risk markers. Eur Heart J
(2007). AR: The macrophage at the crossroads of insulin resistance and atherosclerosis. Circ Res
(2006). C: Adiponectin-induced secretion of interleukin-6 (IL-6), monocyte chemotactic protein-1 (MCP-1, CCL2) and interleukin-8 (IL-8, CXCL8) is impaired in monocytes from patients with type I diabetes. Cardiovasc Diabetol
(2007). Decreased plasma adiponectin is associated with insulin resistance and HDL cholesterol in overweight subjects.
(1999). DeFronzo RA: Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care
(2007). Ferrannini E: Pattern of expression of adiponectin receptors in human adipose tissue depots and its relation to the metabolic state. Int J Obes (Lond)
(2004). Haring HU: Expression of adiponectin receptor mRNA in human skeletal muscle cells is related to in vivo parameters of glucose and lipid metabolism. Diabetes
(2008). Heine RJ: Prognostic value of adiponectin for cardiovascular disease and mortality.
(2003). Kadowaki T: Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature
(2006). Mantzoros CS: Circulating adiponectin and expression of adiponectin receptors in human skeletal muscle: associations with metabolic parameters and insulin resistance and regulation by physical training.
(2007). Mantzoros CS: Gene expression of adiponectin receptors in human visceral and subcutaneous adipose tissue is related to insulin resistance and metabolic parameters and is altered in response to physical training. Diabetes Care
(2005). Margioris AN: Adiponectin induces TNF-alpha and IL-6 in macrophages and promotes tolerance to itself and other pro-inflammatory stimuli. Biochem Biophys Res Commun
(2006). Marmur JD: Adiponectin is an independent predictor of allcause mortality, cardiac mortality, and myocardial infarction in patients presenting with chest pain. Eur Heart J
(2003). Matsuzawa Y: Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol
(1999). Matsuzawa Y: Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun
(2000). Matsuzawa Y: Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol
(2008). MP: Adipokines, insulin resistance, and coronary artery calcification.
(2008). Narendran P: The distribution of adiponectin receptors on human peripheral blood mononuclear cells.
(2004). Ravussin E: Adiponectin receptors gene expression and insulin sensitivity in non-diabetic Mexican Americans with or without a family history of Type 2 diabetes. Diabetologia
(1985). RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia
(2008). Reduced response to adiponectin and lower abundance of adiponectin receptor proteins in type 2 diabetic monocytes. FEBS Lett
(2003). RR: Adiponectin: more than just another fat cell hormone? Diabetes Care
(2008). S: Association of adiponectin with adverse outcome in coronary artery disease patients: results from the AtheroGene study. Eur Heart J
(2010). SA: Genetic variation in the adiponectin receptor 2 (ADIPOR2) gene is associated with coronary artery disease and increased ADIPOR2 expression in peripheral monocytes. Cardiovasc Diabetol
(2007). SA: Glucose transporter expression on the plasma membrane of resting and activated white blood cells.
(2010). Schäffler A: Effects of the new adiponectin paralogous protein CTRP-3 and of LPS on cytokine release from monocytes of patients with type 2 diabetes mellitus. Cytokine
(2004). Spurlock ME: Adiponectin differentially regulates cytokines in porcine macrophages.
(2004). Staels B: Expression of adiponectin receptors in human macrophages and regulation by agonists of the nuclear receptors PPARalpha, PPARgamma, and LXR. Biochem Biophys Res Commun
(2001). Tataranni PA: Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia.
(2004). Tilg H: Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes. Biochem Biophys Res Commun
(2007). Visfatin, TNF-alpha and IL-6 mRNA expression is increased in mononuclear cells from type 2 diabetic women. Horm Metab Res
(2009). Wu YW: Association of circulating matrix metalloproteinase-1, but not adiponectin, with advanced coronary artery disease. Atherosclerosis
(2008). Yamashita S: Adiponectin prevents atherosclerosis by increasing cholesterol efflux from macrophages. Biochem Biophys Res Commun